SRS Acquiom
Sale to Lovell Minnick Partners

Sarepta is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches for the treatment of rare neuromuscular diseases. By applying its' proprietary RNA-targeted platform technologies, Sarepta is able to develop candidate therapies for a broad range of rare diseases and disorders

More Like This

Jan 2024

Frontier Service Partners, a portfolio company of Imperial Capital, has been acquired by Apex Service Partners, a platform of Alpine Investors

Exclusive Financial Advisor

View Details >
Oct 2023

Acquired by Presidio Investors

Exclusive Financial Advisor

View Details >
Jul 2023

Acquisition of Curated Events, a Portfolio Company of Dubin Clark, by MRE Capital

Exclusive Financial Advisor

View Details >